In the present study, immunohistochemistry of tissues from patients with ccRCC were used to investigate SCD1 expression in tumor tissues, and correlations between SCD1 expression level and patient outcomes, as well as clinicopathological factors, were also investigated. This evidence concerns the gene SCD and nonpapillary renal cell carcinoma.